Goldman Sachs
NUVL icon

Goldman Sachs’s Nuvalent NUVL Stock Holding History

Goldman Sachs’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55M Sell
537,158
-57,301
-10% -$5.84M 0.01% 1501
2025
Q4 		$59.8M Buy
594,459
+150,023
+34% +$14.8M 0.01% 1360
2025
Q3 		$38.4M Sell
444,436
-91,009
-17% -$7.2M ﹤0.01% 1649
2025
Q2 		$40.9M Buy
535,445
+81,825
+18% +$5.99M 0.01% 1492
2025
Q1 		$32.2M Buy
453,620
+159,873
+54% +$12.5M 0.01% 1584
2024
Q4 		$23M Buy
293,747
+30,140
+11% +$2.81M ﹤0.01% 1995
2024
Q3 		$27M Sell
263,607
-21,776
-8% -$1.81M ﹤0.01% 1787
2024
Q2 		$21.6M Buy
285,383
+107,014
+60% +$7.61M ﹤0.01% 1828
2024
Q1 		$13.4M Sell
178,369
-40,260
-18% -$3.2M ﹤0.01% 2197
2023
Q4 		$16.1M Buy
218,629
+138,524
+173% +$8.57M ﹤0.01% 2110
2023
Q3 		$3.68M Sell
80,105
-7,716
-9% -$342K ﹤0.01% 3262
2023
Q2 		$3.7M Buy
87,821
+12,911
+17% +$488K ﹤0.01% 3377
2023
Q1 		$1.95M Sell
74,910
-59,934
-44% -$1.77M ﹤0.01% 3882
2022
Q4 		$4.02M Buy
134,844
+101,647
+306% +$2.83M ﹤0.01% 3369
2022
Q3 		$645K Sell
33,197
-7,455
-18% -$125K ﹤0.01% 4804
2022
Q2 		$552K Buy
40,652
+23,805
+141% +$252K ﹤0.01% 5012
2022
Q1 		$234K Buy
16,847
+2,147
+15% +$31.2K ﹤0.01% 5802
2021
Q4 		$280K Buy
+14,700
New +$328K ﹤0.01% 5705

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs's NUVL Position: Q1 2026 in Review

Goldman Sachs reduced its Nuvalent (NUVL) stake by 9.6% in Q1 2026, selling an estimated $5.84M and leaving 537,158 shares worth $55M. The position accounts for 0.01% of the portfolio, ranked #1501.

Goldman Sachs first reported a position in NUVL in Q4 2021 and has held it in 18 quarters since. The position peaked at $59.8M in Q4 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Goldman Sachs held 537,158 shares of Nuvalent worth $55M as of Q1 2026.
  • Goldman Sachs sold 57,301 Nuvalent shares in Q1 2026, an estimated $5.84M.
  • Nuvalent made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1501 holding.
  • Goldman Sachs first reported a position in Nuvalent in Q4 2021 and has held it in 18 quarters since.
  • Goldman Sachs's Nuvalent position peaked at $59.8M in Q4 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.